Australia: Dr Patrick Thomas is an Affiliate Research Fellow within the Queensland Bladder Cancer Initiative (QBCI) at Queensland University of Technology, Australia. His research focuses on urological cancers and tumour immunology, with the goal of developing precision medicine tools to predict therapy response in bladder and prostate cancer patients.
His work centres on multiparametric immunophenotyping of tumour-localised immune cells, co-culture models for therapy prediction, and spatial profiling of high-risk and aggressive variants of bladder cancer. He has received over 12 national and international awards for excellence in cancer research and currently serves as Scientific Director of the Ron Monaghan Foundation.
Dr Thomas is also a passionate advocate for improving the lives of bladder cancer patients. He champions greater research funding and the translation of emerging scientific concepts into community-focused initiatives. His work aims to bridge the gap between cutting-edge research and real-world patient outcomes, ensuring that advances in precision medicine and immunotherapy reach those who need them most.
